Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis
Conclusion This study demonstrates that, in the nasal respiratory mucosa of patients with vasomotor rhinitis, oxidative stress following peroxynitrite formation is confined to the respiratory epithelium. This suggests that the role of peroxynitrite in vasomotor rhinitis differs from its role in othe...
Gespeichert in:
Veröffentlicht in: | Acta oto-laryngologica 2005-01, Vol.125 (1), p.65-71 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 71 |
---|---|
container_issue | 1 |
container_start_page | 65 |
container_title | Acta oto-laryngologica |
container_volume | 125 |
creator | Giannessi, Francesco Ursino, Francesco Fattori, Bruno Giambelluca, M. Anita Scavuzzo, Maria C. Ceccarelli, Francesca Ruffoli, Riccardo |
description | Conclusion
This study demonstrates that, in the nasal respiratory mucosa of patients with vasomotor rhinitis, oxidative stress following peroxynitrite formation is confined to the respiratory epithelium. This suggests that the role of peroxynitrite in vasomotor rhinitis differs from its role in other diseases of the respiratory tract. The results of this study also support the concept that different pathogenetic mechanisms are probably involved in vasomotor rhinitis.
Objective
Previous studies indicated that nitric oxide (NO) is involved in the pathogenesis of vasomotor rhinitis, strong expression of NO synthase being detected in the smooth muscle cells of the cavernous sinuses and in the respiratory epithelium. However, most adverse effects of high levels of NO originate from the reaction of NO with superoxide anions to form peroxynitrite. Therefore, in this study we evaluated the involvement of peroxynitrite in the pathogenesis of vasomotor rhinitis.
Material and methods
Sites of peroxynitrite formation were identified by immunolabelling for 3-nitrotyrosine (3NT), its footprint in tissues. Samples of nasal mucosa were obtained from vasomotor rhinitis patients and from control subjects who had undergone corrective surgery of the nasal septum. All samples were obtained by reduction of the inferior turbinate.
Results
Examination of specimens from vasomotor rhinitis patients revealed that 3NT is absent in epithelium with a normal appearance, cells of the subepithelial connective tissue, the glands and the blood vessels, including the cavernous sinuses. In contrast, intense 3NT immunolabelling was found in the disrupted respiratory epithelium. 3NT was not present in any of the specimens from control subjects. |
doi_str_mv | 10.1080/00016480410016982 |
format | Article |
fullrecord | <record><control><sourceid>informahealthcare_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16411388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1080_00016480410016982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-bc2b98cb1b719993ee3709ae54d1ac2a400b5ee17f0326febdab520af37038dc3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfJxeNqstmvoBcpfhQKXvS8zGazbMpuUpLUsv56s7RSROglyZDnGWZehK4puaOkIPeEEJolBUno-OBFfIKmNEtpFMcpPUXT8T8KAJ-gC-dWY8mL9BxNaJpznub5FG0Xfb_RplXOG9HKXgnocGfCqb7BK6OxaTCLtPLW-MEap7TESmPfSqzBBdhKt1YWvLED7jfCOBiVdZCl9g5vlW_xFzjTm4Bg26rQS7lLdNZA5-TV_p6hz5fnj_lbtHx_XcyflpFIWOKjSsQVL0RFq5xyzpmULCccZJrUFEQMCSFVKiXNG8LirJFVDVUaE2gCxopasBmiu74izO6sbMq1VT3YoaSkHEMs_4UYnJuds95UvawPxj61ANzuAXAhqcaCFsoduCyhlBVF4B53nNKNsT1sje3q0sPQGfsrsWNzPPzRWwmdbwVYWa7MxuqQ25EtfgDo_KKY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>Giannessi, Francesco ; Ursino, Francesco ; Fattori, Bruno ; Giambelluca, M. Anita ; Scavuzzo, Maria C. ; Ceccarelli, Francesca ; Ruffoli, Riccardo</creator><creatorcontrib>Giannessi, Francesco ; Ursino, Francesco ; Fattori, Bruno ; Giambelluca, M. Anita ; Scavuzzo, Maria C. ; Ceccarelli, Francesca ; Ruffoli, Riccardo</creatorcontrib><description>Conclusion
This study demonstrates that, in the nasal respiratory mucosa of patients with vasomotor rhinitis, oxidative stress following peroxynitrite formation is confined to the respiratory epithelium. This suggests that the role of peroxynitrite in vasomotor rhinitis differs from its role in other diseases of the respiratory tract. The results of this study also support the concept that different pathogenetic mechanisms are probably involved in vasomotor rhinitis.
Objective
Previous studies indicated that nitric oxide (NO) is involved in the pathogenesis of vasomotor rhinitis, strong expression of NO synthase being detected in the smooth muscle cells of the cavernous sinuses and in the respiratory epithelium. However, most adverse effects of high levels of NO originate from the reaction of NO with superoxide anions to form peroxynitrite. Therefore, in this study we evaluated the involvement of peroxynitrite in the pathogenesis of vasomotor rhinitis.
Material and methods
Sites of peroxynitrite formation were identified by immunolabelling for 3-nitrotyrosine (3NT), its footprint in tissues. Samples of nasal mucosa were obtained from vasomotor rhinitis patients and from control subjects who had undergone corrective surgery of the nasal septum. All samples were obtained by reduction of the inferior turbinate.
Results
Examination of specimens from vasomotor rhinitis patients revealed that 3NT is absent in epithelium with a normal appearance, cells of the subepithelial connective tissue, the glands and the blood vessels, including the cavernous sinuses. In contrast, intense 3NT immunolabelling was found in the disrupted respiratory epithelium. 3NT was not present in any of the specimens from control subjects.</description><identifier>ISSN: 0001-6489</identifier><identifier>EISSN: 1651-2251</identifier><identifier>DOI: 10.1080/00016480410016982</identifier><identifier>PMID: 15799577</identifier><identifier>CODEN: AOLAAJ</identifier><language>eng</language><publisher>Stockholm: Informa UK Ltd</publisher><subject>Adult ; Biological and medical sciences ; Cavernous Sinus - drug effects ; Cavernous Sinus - immunology ; Cavernous Sinus - pathology ; Female ; Humans ; Immunohistochemistry ; Male ; Medical sciences ; Mucosa ; Muscle, Smooth - drug effects ; Muscle, Smooth - immunology ; Nitric Oxide - adverse effects ; Nitric Oxide - immunology ; nitrotyrosine ; Non tumoral diseases ; nose ; Otorhinolaryngology. Stomatology ; Peroxynitrous Acid - biosynthesis ; Peroxynitrous Acid - immunology ; Respiratory Mucosa - drug effects ; Respiratory Mucosa - immunology ; Respiratory Mucosa - pathology ; Rhinitis, Vasomotor - immunology ; Rhinitis, Vasomotor - pathology ; Rhinomanometry ; Tyrosine - analogs & derivatives ; Tyrosine - immunology ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology ; vasomotor rhinitis</subject><ispartof>Acta oto-laryngologica, 2005-01, Vol.125 (1), p.65-71</ispartof><rights>2005 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2005</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-bc2b98cb1b719993ee3709ae54d1ac2a400b5ee17f0326febdab520af37038dc3</citedby><cites>FETCH-LOGICAL-c434t-bc2b98cb1b719993ee3709ae54d1ac2a400b5ee17f0326febdab520af37038dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/00016480410016982$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/00016480410016982$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16411388$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15799577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giannessi, Francesco</creatorcontrib><creatorcontrib>Ursino, Francesco</creatorcontrib><creatorcontrib>Fattori, Bruno</creatorcontrib><creatorcontrib>Giambelluca, M. Anita</creatorcontrib><creatorcontrib>Scavuzzo, Maria C.</creatorcontrib><creatorcontrib>Ceccarelli, Francesca</creatorcontrib><creatorcontrib>Ruffoli, Riccardo</creatorcontrib><title>Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis</title><title>Acta oto-laryngologica</title><addtitle>Acta Otolaryngol</addtitle><description>Conclusion
This study demonstrates that, in the nasal respiratory mucosa of patients with vasomotor rhinitis, oxidative stress following peroxynitrite formation is confined to the respiratory epithelium. This suggests that the role of peroxynitrite in vasomotor rhinitis differs from its role in other diseases of the respiratory tract. The results of this study also support the concept that different pathogenetic mechanisms are probably involved in vasomotor rhinitis.
Objective
Previous studies indicated that nitric oxide (NO) is involved in the pathogenesis of vasomotor rhinitis, strong expression of NO synthase being detected in the smooth muscle cells of the cavernous sinuses and in the respiratory epithelium. However, most adverse effects of high levels of NO originate from the reaction of NO with superoxide anions to form peroxynitrite. Therefore, in this study we evaluated the involvement of peroxynitrite in the pathogenesis of vasomotor rhinitis.
Material and methods
Sites of peroxynitrite formation were identified by immunolabelling for 3-nitrotyrosine (3NT), its footprint in tissues. Samples of nasal mucosa were obtained from vasomotor rhinitis patients and from control subjects who had undergone corrective surgery of the nasal septum. All samples were obtained by reduction of the inferior turbinate.
Results
Examination of specimens from vasomotor rhinitis patients revealed that 3NT is absent in epithelium with a normal appearance, cells of the subepithelial connective tissue, the glands and the blood vessels, including the cavernous sinuses. In contrast, intense 3NT immunolabelling was found in the disrupted respiratory epithelium. 3NT was not present in any of the specimens from control subjects.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cavernous Sinus - drug effects</subject><subject>Cavernous Sinus - immunology</subject><subject>Cavernous Sinus - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mucosa</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - immunology</subject><subject>Nitric Oxide - adverse effects</subject><subject>Nitric Oxide - immunology</subject><subject>nitrotyrosine</subject><subject>Non tumoral diseases</subject><subject>nose</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Peroxynitrous Acid - biosynthesis</subject><subject>Peroxynitrous Acid - immunology</subject><subject>Respiratory Mucosa - drug effects</subject><subject>Respiratory Mucosa - immunology</subject><subject>Respiratory Mucosa - pathology</subject><subject>Rhinitis, Vasomotor - immunology</subject><subject>Rhinitis, Vasomotor - pathology</subject><subject>Rhinomanometry</subject><subject>Tyrosine - analogs & derivatives</subject><subject>Tyrosine - immunology</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><subject>vasomotor rhinitis</subject><issn>0001-6489</issn><issn>1651-2251</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfJxeNqstmvoBcpfhQKXvS8zGazbMpuUpLUsv56s7RSROglyZDnGWZehK4puaOkIPeEEJolBUno-OBFfIKmNEtpFMcpPUXT8T8KAJ-gC-dWY8mL9BxNaJpznub5FG0Xfb_RplXOG9HKXgnocGfCqb7BK6OxaTCLtPLW-MEap7TESmPfSqzBBdhKt1YWvLED7jfCOBiVdZCl9g5vlW_xFzjTm4Bg26rQS7lLdNZA5-TV_p6hz5fnj_lbtHx_XcyflpFIWOKjSsQVL0RFq5xyzpmULCccZJrUFEQMCSFVKiXNG8LirJFVDVUaE2gCxopasBmiu74izO6sbMq1VT3YoaSkHEMs_4UYnJuds95UvawPxj61ANzuAXAhqcaCFsoduCyhlBVF4B53nNKNsT1sje3q0sPQGfsrsWNzPPzRWwmdbwVYWa7MxuqQ25EtfgDo_KKY</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Giannessi, Francesco</creator><creator>Ursino, Francesco</creator><creator>Fattori, Bruno</creator><creator>Giambelluca, M. Anita</creator><creator>Scavuzzo, Maria C.</creator><creator>Ceccarelli, Francesca</creator><creator>Ruffoli, Riccardo</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Taylor and Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200501</creationdate><title>Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis</title><author>Giannessi, Francesco ; Ursino, Francesco ; Fattori, Bruno ; Giambelluca, M. Anita ; Scavuzzo, Maria C. ; Ceccarelli, Francesca ; Ruffoli, Riccardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-bc2b98cb1b719993ee3709ae54d1ac2a400b5ee17f0326febdab520af37038dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cavernous Sinus - drug effects</topic><topic>Cavernous Sinus - immunology</topic><topic>Cavernous Sinus - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mucosa</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - immunology</topic><topic>Nitric Oxide - adverse effects</topic><topic>Nitric Oxide - immunology</topic><topic>nitrotyrosine</topic><topic>Non tumoral diseases</topic><topic>nose</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Peroxynitrous Acid - biosynthesis</topic><topic>Peroxynitrous Acid - immunology</topic><topic>Respiratory Mucosa - drug effects</topic><topic>Respiratory Mucosa - immunology</topic><topic>Respiratory Mucosa - pathology</topic><topic>Rhinitis, Vasomotor - immunology</topic><topic>Rhinitis, Vasomotor - pathology</topic><topic>Rhinomanometry</topic><topic>Tyrosine - analogs & derivatives</topic><topic>Tyrosine - immunology</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><topic>vasomotor rhinitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giannessi, Francesco</creatorcontrib><creatorcontrib>Ursino, Francesco</creatorcontrib><creatorcontrib>Fattori, Bruno</creatorcontrib><creatorcontrib>Giambelluca, M. Anita</creatorcontrib><creatorcontrib>Scavuzzo, Maria C.</creatorcontrib><creatorcontrib>Ceccarelli, Francesca</creatorcontrib><creatorcontrib>Ruffoli, Riccardo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta oto-laryngologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannessi, Francesco</au><au>Ursino, Francesco</au><au>Fattori, Bruno</au><au>Giambelluca, M. Anita</au><au>Scavuzzo, Maria C.</au><au>Ceccarelli, Francesca</au><au>Ruffoli, Riccardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis</atitle><jtitle>Acta oto-laryngologica</jtitle><addtitle>Acta Otolaryngol</addtitle><date>2005-01</date><risdate>2005</risdate><volume>125</volume><issue>1</issue><spage>65</spage><epage>71</epage><pages>65-71</pages><issn>0001-6489</issn><eissn>1651-2251</eissn><coden>AOLAAJ</coden><abstract>Conclusion
This study demonstrates that, in the nasal respiratory mucosa of patients with vasomotor rhinitis, oxidative stress following peroxynitrite formation is confined to the respiratory epithelium. This suggests that the role of peroxynitrite in vasomotor rhinitis differs from its role in other diseases of the respiratory tract. The results of this study also support the concept that different pathogenetic mechanisms are probably involved in vasomotor rhinitis.
Objective
Previous studies indicated that nitric oxide (NO) is involved in the pathogenesis of vasomotor rhinitis, strong expression of NO synthase being detected in the smooth muscle cells of the cavernous sinuses and in the respiratory epithelium. However, most adverse effects of high levels of NO originate from the reaction of NO with superoxide anions to form peroxynitrite. Therefore, in this study we evaluated the involvement of peroxynitrite in the pathogenesis of vasomotor rhinitis.
Material and methods
Sites of peroxynitrite formation were identified by immunolabelling for 3-nitrotyrosine (3NT), its footprint in tissues. Samples of nasal mucosa were obtained from vasomotor rhinitis patients and from control subjects who had undergone corrective surgery of the nasal septum. All samples were obtained by reduction of the inferior turbinate.
Results
Examination of specimens from vasomotor rhinitis patients revealed that 3NT is absent in epithelium with a normal appearance, cells of the subepithelial connective tissue, the glands and the blood vessels, including the cavernous sinuses. In contrast, intense 3NT immunolabelling was found in the disrupted respiratory epithelium. 3NT was not present in any of the specimens from control subjects.</abstract><cop>Stockholm</cop><pub>Informa UK Ltd</pub><pmid>15799577</pmid><doi>10.1080/00016480410016982</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6489 |
ispartof | Acta oto-laryngologica, 2005-01, Vol.125 (1), p.65-71 |
issn | 0001-6489 1651-2251 |
language | eng |
recordid | cdi_pascalfrancis_primary_16411388 |
source | MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
subjects | Adult Biological and medical sciences Cavernous Sinus - drug effects Cavernous Sinus - immunology Cavernous Sinus - pathology Female Humans Immunohistochemistry Male Medical sciences Mucosa Muscle, Smooth - drug effects Muscle, Smooth - immunology Nitric Oxide - adverse effects Nitric Oxide - immunology nitrotyrosine Non tumoral diseases nose Otorhinolaryngology. Stomatology Peroxynitrous Acid - biosynthesis Peroxynitrous Acid - immunology Respiratory Mucosa - drug effects Respiratory Mucosa - immunology Respiratory Mucosa - pathology Rhinitis, Vasomotor - immunology Rhinitis, Vasomotor - pathology Rhinomanometry Tyrosine - analogs & derivatives Tyrosine - immunology Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology vasomotor rhinitis |
title | Immunohistochemical localization of 3-nitrotyrosine in the nasal respiratory mucosa of patients with vasomotor rhinitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A41%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunohistochemical%20localization%20of%203-nitrotyrosine%20in%20the%20nasal%20respiratory%20mucosa%20of%20patients%20with%20vasomotor%20rhinitis&rft.jtitle=Acta%20oto-laryngologica&rft.au=Giannessi,%20Francesco&rft.date=2005-01&rft.volume=125&rft.issue=1&rft.spage=65&rft.epage=71&rft.pages=65-71&rft.issn=0001-6489&rft.eissn=1651-2251&rft.coden=AOLAAJ&rft_id=info:doi/10.1080/00016480410016982&rft_dat=%3Cinformahealthcare_pasca%3E10_1080_00016480410016982%3C/informahealthcare_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15799577&rfr_iscdi=true |